Navigation Links
E. coli strains resistant to a common antibiotic

Food contaminated with a strain of drug-resistant E. coli has emerged as a possible new source of urinary tract infections. E. coli is a normal inhabitant of the digestive tract that can cause both intestinal upsets and urinary infections. But while E. coli from bad food is a frequent cause of diarrhoea and other digestive miseries, urinary tract infections were thought until now to result mostly from inadvertent contact with the victim's own feces. Urinary tract infections are common, especially among women, and cause painful and frequent urination. //

The new research found that a single, genetically identical strain was responsible for outbreaks of urinary tract infections among women in California, Michigan and Minnesota. Because the germs are exactly the same, investigators assume they came from the same source, and the most likely such source is food.

The research, conducted at the University of California at Berkeley, was based on analysis of 302 cases. "We were really, really surprised," said researcher Amee R. Manges at Berkeley. "When we looked at these organisms from these various different women, many of them turned out to be the same. We weren't anticipating that."

The researchers looked specifically at infections caused by E. coli strains resistant to a common antibiotic, trimethoprim-sulfamethoxazole, sold as Bactrim or Septra. They found the same strain caused 51 percent of the drug-resistant infections at Berkeley, 38 percent in Michigan and 39 percent in Minnesota.


'"/>




Page: 1

Related medicine news :

1. African HIV strains more resistant to anti HIV drugs
2. Hormone restrains appetite in man
3. Bioengineering production strains - Microbia develops new methods
4. Fluorescent markers to distinguish Trypanosoma brucei strains causing Sleeping Sickness
5. Detection of Weak strains of bird flu virus – Target of European Unio
6. Resistant Influenza strains creates panic in US
7. Multiple infectious disease strains can coexist
8. Threat posed by highly resistant strains of TB
9. African HIV strains more resistant to anti HIV drugs
10. Gene researchers make Malaria-resistant mosquito
11. Vaccine Reduces antibiotic-resistant infections in Children
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/18/2017)... ... August 18, 2017 , ... The Golseth Agency, a Texas based insurance ... is spearheading a regional charity campaign organized to provide support to Christina Upchurch and ... this year, Christina and her children returned from out of town to find her ...
(Date:8/18/2017)... Raton, Fl (PRWEB) , ... August 18, 2017 ... ... largest network of highly trained practitioners specializing in bioidentical hormone replacement therapy and ... associated with hormone imbalance and conditions of aging, such as menopause, andropause, thyroid ...
(Date:8/18/2017)... ... ... Alcovit, a lime-flavored beverage that rids the body of toxins linked to ... available through Jet.com. , After 25 years of development, the company released its ... quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun with friends ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... and call tracking and monitoring solutions, announced today the launch of a redesigned ... a modern navigation and aesthetic, fully responsive design, and an enhanced search directory ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Dangerous Inheritance”: a mystery about saving the family ... is from Southwest Nebraska where she was raised on a farm. As Diane ... is fictional, but the friendships and mantra of ‘neighbors helping neighbors’ have always been ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017  Axium Pharmaceuticals Inc., the creator of ... to be in the beginning stages of an IPO. ... epilepsy medications with the average cost of a prescription epilepsy drug being ... AXIUM ... Another staggering figure is the fact that ...
(Date:8/14/2017)... TIKVAH, Israel , Aug. 15, 2017 ... developer of adult stem cell technologies for neurodegenerative diseases, ... 30, 2017. "We ... pivotal Phase 3 trial to investigate NurOwn ® ... Chief Executive Officer of BrainStorm. "We have agreements with ...
(Date:8/8/2017)... 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... its financial results for the second quarter ended June ... second quarter 2017 and to date: ... programs for the Company,s lead project, BL-8040: ... with BL-8040 as novel stem cell mobilization treatment for ...
Breaking Medicine Technology: